Lu, B., Liu, N., Zhao, W., Chen, H., Shao, Y., Lu, H., Liu, S., Yang, J., Zheng, Y., Ding, J., Chai, D., Mao, L.

Background
Prostate-specific membrane antigen (PSMA)-based vaccination represents a promising immunotherapeutic strategy for prostate cancer; however, its efficacy remains constrained by tumor-induced immune evasion and insufficient activation of anti…